Profile
James T.
O'Brien was the founder who established O'Brien Pharmaceuticals, Inc. in 1986, where he served as President & Chief Executive Officer until 2011.
He was also the President of O'Brien Marketing & Communications, Inc. Mr. O'Brien's former positions include Vice President-Marketing & Sales at Sandoz Pharmaceuticals Corp.
from 1980 to 1986, President & Chief Operating Officer at Elan Corp.
Plc from 1989 to 1991, Director at Cognovant, Inc., Independent Director at Derma Sciences, Inc. from 2011 to 2013, and Chairman at Benedictine College.
Mr. O'Brien earned his undergraduate degree from Benedictine College in 1960.
Former positions of James T. O'Brien
| Companies | Position | End |
|---|---|---|
| DERMA SCIENCES INC | Director/Board Member | 31/03/2013 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | President | 01/01/1991 |
| Sandoz Pharmaceuticals Corp. | Sales & Marketing | 01/01/1986 |
Cognovant, Inc.
 Cognovant, Inc. Packaged SoftwareTechnology Services Cognovant, Inc. engaged in computer applications and software development. The company was headquartered in Kansas City, MO. | Director/Board Member | - |
| O'Brien Pharmaceuticals, Inc. | Founder | - |
Training of James T. O'Brien
| Benedictine College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Derma Sciences, Inc.
 Derma Sciences, Inc. Medical SpecialtiesHealth Technology Derma Sciences, Inc. is a medical device company. It operates through the following product segments: Advanced Wound Care (AWC), Traditional Wound Care (TWC), and Other. The AWC segment includes both novel and otherwise differentiated dressings, devices, and skin substitutes designed to promote wound healing and prevent infection. The TWC segment focuses on commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners, and skin care products. The company was founded on September 10, 1984 and is headquartered in Princeton, NJ. | Health Technology |
| O'Brien Marketing & Communications, Inc. | |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
| O'Brien Pharmaceuticals, Inc. | |
| Sandoz Pharmaceuticals Corp. | |
Cognovant, Inc.
Cognovant, Inc. Packaged SoftwareTechnology Services Cognovant, Inc. engaged in computer applications and software development. The company was headquartered in Kansas City, MO. | Technology Services |
- Stock Market
- Insiders
- James T. O'Brien
